Speak YOUR

truth

ABOUT MANAGING YOUR HEMOPHILIA A WITH OR WITHOUT INHIBITORS

Are you making trade-offs by compromising on bleed protection or ease of administration?

^aA study asked people with hemophilia how many bleeds they had in the last 2 weeks, and then checked if the answers matched what was recorded in their medical records. These results might show that some bleeds are not always reported to the doctor. Limitations of this data may include patients' willingness to report their bleeds, whether patients accurately recalled their number of bleeds, or the correctness of their medical records.

Nikola lives with hemophilia A.

WHAT ARE TREATMENT
TRADE-OFFS?

Trade-offs are part of everyday life and may mean making difficult choices. With hemophilia A with or without inhibitors, it can mean accepting the difficulties of treatment administration to prevent or reduce bleeds, or sacrificing bleed protection for easier administration.

Researchers are studying coagulation markers to help them understand how non-factor treatments work.

These coagulation markers include:

Thrombin generation: The ability of the body to make thrombin, a key clotting protein
Clot formation: The process your body uses to stop bleeding by forming a plug that seals a cut or injury in a blood vessel

Learn about coagulation markers